[go: up one dir, main page]

NO2783694T3 - - Google Patents

Info

Publication number
NO2783694T3
NO2783694T3 NO14162925A NO14162925A NO2783694T3 NO 2783694 T3 NO2783694 T3 NO 2783694T3 NO 14162925 A NO14162925 A NO 14162925A NO 14162925 A NO14162925 A NO 14162925A NO 2783694 T3 NO2783694 T3 NO 2783694T3
Authority
NO
Norway
Application number
NO14162925A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2783694T3 publication Critical patent/NO2783694T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/005Trypanosoma antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/858Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO14162925A 2007-09-13 2008-09-05 NO2783694T3 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0717864.3A GB0717864D0 (en) 2007-09-13 2007-09-13 Peptide sequences and compositions
EP11178673A EP2407172A1 (en) 2007-09-13 2008-09-05 Peptide sequences and compositions
EP08803793A EP2182972A2 (en) 2007-09-13 2008-09-05 Peptide sequences and compositions

Publications (1)

Publication Number Publication Date
NO2783694T3 true NO2783694T3 (no) 2018-07-28

Family

ID=38658898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14162925A NO2783694T3 (no) 2007-09-13 2008-09-05

Country Status (25)

Country Link
US (2) US8986703B2 (no)
EP (4) EP2567706A3 (no)
JP (3) JP2010539127A (no)
CN (1) CN101815526B (no)
AR (1) AR068428A1 (no)
AU (1) AU2008297213B2 (no)
BR (1) BRPI0816330A2 (no)
CA (1) CA2699467A1 (no)
CL (1) CL2008002727A1 (no)
CO (1) CO6270336A2 (no)
DK (1) DK2783694T3 (no)
ES (1) ES2670859T3 (no)
GB (1) GB0717864D0 (no)
HU (1) HUE038953T2 (no)
MX (1) MX2010002025A (no)
NO (1) NO2783694T3 (no)
PE (1) PE20090682A1 (no)
PL (1) PL2783694T3 (no)
PT (1) PT2783694T (no)
RU (1) RU2466737C2 (no)
SG (1) SG187401A1 (no)
TR (1) TR201807414T4 (no)
TW (1) TWI548646B (no)
WO (1) WO2009034041A2 (no)
ZA (1) ZA201000914B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968324B2 (en) * 2004-08-13 2011-06-28 Barry J Marshall Helicobacter system and uses thereof
JP5429804B2 (ja) * 2007-09-26 2014-02-26 独立行政法人国立循環器病研究センター 体内に存在する病因物質の低下剤
WO2009131730A2 (en) * 2008-01-31 2009-10-29 University Of Iowa Research Foundation IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS
JP5344558B2 (ja) * 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン
FR2955393B1 (fr) * 2010-01-18 2015-12-11 Inst Rech Developpement Ird Methode pour evaluer l'efficacite de strategies de lutte anti-vectorielle dans le controle du paludisme et des arboviroses
KR101297037B1 (ko) * 2010-03-26 2013-08-14 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도
BR112015021162A2 (pt) 2013-03-08 2017-10-10 Taiho Pharmaceutical Co Ltd peptídeo tendo 5 epítopos de ctl ligados
US10898555B2 (en) * 2013-07-02 2021-01-26 Japanese Foundation For Cancer Research Cellular immunity inducing vaccine
ES2796301T3 (es) 2013-10-21 2020-11-26 Taiho Pharmaceutical Co Ltd Nuevo péptido con cuatro epítopos CTL unidos
CN104356216B (zh) * 2014-10-09 2017-03-01 昆明医科大学 版纳绳蚋防御肽SibaDef及其基因和应用
WO2016126457A1 (en) * 2015-02-02 2016-08-11 Yale University Mosquito saliva protein malaria vaccine
US9913903B2 (en) 2015-08-06 2018-03-13 Grifols Worldwide Operations Limited Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
US10570194B2 (en) 2015-08-06 2020-02-25 Grifols Worldwide Operations Limited Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
JP6893765B2 (ja) * 2016-07-15 2021-06-23 森山 雅美 人以外の陸上動物用のウイルス感染症に対する抗体誘導剤とその補助剤
CN107236028B (zh) * 2017-07-05 2020-12-04 贵州医科大学 白纹伊蚊唾液34K2重组蛋白在DENV2感染HaCaT细胞中的应用
US12251447B2 (en) 2018-06-29 2025-03-18 Taiho Pharmaceutical Co., Ltd. Combined formulation comprising four linked cytotoxic T lymphocyte (CTL) epitopes and a PD-1 pathway inhibitor and methods of use thereof to treat cancer
US20220290248A1 (en) * 2019-08-13 2022-09-15 Tata Consultancy Services Limited System and method for assessing the risk of colorectal cancer
WO2021028861A2 (en) * 2019-08-13 2021-02-18 Tata Consultancy Services Limited System and method for assessing the risk of prediabetes
KR102615021B1 (ko) * 2021-10-14 2023-12-20 주식회사 메디트 3차원 스캐너의 스캔 이미지 정렬 방법, 장치 및 명령을 기록한 기록매체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05004714A (es) * 2002-10-29 2006-03-17 Us Gov Health & Human Serv Polipeptidos de lutzomyia longipalpis y metodos de uso.

Also Published As

Publication number Publication date
EP2407172A1 (en) 2012-01-18
JP2016135767A (ja) 2016-07-28
GB0717864D0 (en) 2007-10-24
TR201807414T4 (tr) 2018-06-21
EP2783694B1 (en) 2018-02-28
PE20090682A1 (es) 2009-06-22
AR068428A1 (es) 2009-11-18
EP2783694A3 (en) 2015-01-07
CN101815526B (zh) 2014-03-19
EP2182972A2 (en) 2010-05-12
US20100297187A1 (en) 2010-11-25
US8986703B2 (en) 2015-03-24
CO6270336A2 (es) 2011-04-20
WO2009034041A3 (en) 2009-06-25
EP2567706A2 (en) 2013-03-13
HUE038953T2 (hu) 2018-12-28
WO2009034041A2 (en) 2009-03-19
TWI548646B (zh) 2016-09-11
PL2783694T3 (pl) 2018-10-31
RU2466737C2 (ru) 2012-11-20
ES2670859T3 (es) 2018-06-01
ZA201000914B (en) 2011-04-28
MX2010002025A (es) 2010-03-15
AU2008297213A1 (en) 2009-03-19
PT2783694T (pt) 2018-06-07
JP6227018B2 (ja) 2017-11-08
AU2008297213B2 (en) 2013-01-24
CA2699467A1 (en) 2009-03-19
USRE47222E1 (en) 2019-02-05
TW200920398A (en) 2009-05-16
BRPI0816330A2 (pt) 2015-04-14
CN101815526A (zh) 2010-08-25
EP2783694A2 (en) 2014-10-01
RU2010114597A (ru) 2011-10-20
DK2783694T3 (en) 2018-06-14
CL2008002727A1 (es) 2009-03-06
JP5981883B2 (ja) 2016-08-31
SG187401A1 (en) 2013-02-28
JP2010539127A (ja) 2010-12-16
EP2567706A3 (en) 2013-06-12
JP2013240330A (ja) 2013-12-05

Similar Documents

Publication Publication Date Title
NO2783694T3 (no)
CN300802774S (zh) 垫子(244)
CN300728233S (zh) 扇叶
CN300877610S (zh) 投光灯(jx-tgd38)
CN300869995S (zh) 拨套
CN300852826S (zh) Mp3播放器(12)
CN300851597S (zh) 衣柜(610)
CN300850599S (zh) 密码防盗箱
CN300846394S (zh) 逆变焊机(mma160)
CN300840786S (zh) 包装盒(竹炭纤维被)
CN300834298S (zh) 汽车
CN300726093S (zh) 餐具笼(花瓶形2002)
CN300830765S (zh) 卡通画页(七摄氏度07011)
CN300819735S (zh) 吊灯(u6029-6h)
CN300817629S (zh) 玩具靠垫(2)
CN300816416S (zh) 浴巾架(单杆18001)
CN300810577S (zh) 型材(grp5514)
CN300726079S (zh) 化妆箱
CN300726251S (zh) 壁纸(3)
CN300789588S (zh) 座垫(110)
CN300771675S (zh) 毛巾(2007-51)
CN300764007S (zh) 开关(2)
CN300729457S (zh) 酒瓶包装盒(和谐高炉家酒2)
CN300728912S (zh) 组合式操作台
CN300728807S (zh) 玻璃(旺藤)